Literature DB >> 6975184

Potency of killed plague vaccines prepared from avirulent Yersinia pestis.

J E Williams, P L Altieri, S Berman, J P Lowenthal, D C Cavanaugh.   

Abstract

Killed plague vaccines prepared from avirulent strains A1122 and EV76S of Yersinia pestis were more effective in mouse potency tests than samples of Plague Vaccine, USP, prepared from killed Y. pestis of the virulent strain 195/P. Manufacture of vaccine from avirulent Y. pestis would obviate requirements for the large containment facilities that are currently needed for producing Plague Vaccine, USP.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6975184      PMCID： PMC2395990     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  6 in total

1.  The immune response of the guinea pig to the antigens of Pasteurella pestis.

Authors:  M L SPIVACK; L FOSTER; A LARSON; T H CHEN; E E BAKER; K F MEYER
Journal:  J Immunol       Date:  1958-02       Impact factor: 5.422

2.  Virulence in Pasteurella pestis.

Authors:  E ENGLESBERG; T H CHEN; J B LEVY; L E FOSTER; K F MEYER
Journal:  Science       Date:  1954-03-26       Impact factor: 47.728

3.  Plague immunization. V. Indirect evidence for the efficacy of plague vaccine.

Authors:  D C Cavanaugh; B L Elisberg; C H Llewellyn; J D Marshall; J H Rust; J E Williams; K F Meyer
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

4.  Freeze-drying various attenuated strains of Pasteurella pestis.

Authors:  S Berman; P L Altieri; A Groffinger; J P Lowenthal
Journal:  Cryobiology       Date:  1970 Jul-Aug       Impact factor: 2.487

5.  Measuring the efficacy of vaccination in affording protection against plague.

Authors:  J E Williams; D C Cavanaugh
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

6.  Effectiveness of live or killed plague vaccines in man.

Authors:  K F Meyer
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408
  6 in total
  9 in total

1.  Quantifying serum antiplague antibody with a fiber-optic biosensor.

Authors:  G P Anderson; K D King; L K Cao; M Jacoby; F S Ligler; J Ezzell
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

2.  High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.

Authors:  Duraisamy Ponnusamy; Eric C Fitts; Jian Sha; Tatiana E Erova; Elena V Kozlova; Michelle L Kirtley; Bethany L Tiner; Jourdan A Andersson; Ashok K Chopra
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

3.  Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Authors:  E D Williamson; H C Flick-Smith; C Lebutt; C A Rowland; S M Jones; E L Waters; R J Gwyther; J Miller; P J Packer; M Irving
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.

Authors:  Shixia Wang; Innocent Mboudjeka; Jon D Goguen; Shan Lu
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

5.  Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.

Authors:  Shixia Wang; Jon D Goguen; Fusheng Li; Shan Lu
Journal:  Vaccine       Date:  2011-01-01       Impact factor: 3.641

Review 6.  Yersinia pestis--etiologic agent of plague.

Authors:  R D Perry; J D Fetherston
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

7.  Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.

Authors:  Bethany L Tiner; Jian Sha; Duraisamy Ponnusamy; Wallace B Baze; Eric C Fitts; Vsevolod L Popov; Christina J van Lier; Tatiana E Erova; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2015-10-07

Review 8.  Demand for nonhuman primate resources in the age of biodefense.

Authors:  Jean L Patterson; Richardo Carrion
Journal:  ILAR J       Date:  2005

9.  Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine.

Authors:  Sergei Biryukov; Jennifer L Dankmeyer; Zain Shamsuddin; Ivan Velez; Nathaniel O Rill; Raysa Rosario-Acevedo; Christopher P Klimko; Jennifer L Shoe; Melissa Hunter; Michael D Ward; Lisa H Cazares; David P Fetterer; Joel A Bozue; Patricia L Worsham; Christopher K Cote; Kei Amemiya
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.